Vishvanath Nene Selected Research

Theileriasis

1/2022	Systematic Determination of TCR-Antigen and Peptide-MHC Binding Kinetics among Field Variants of a Theileria parva Polymorphic CTL Epitope.
1/2019	Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever.
1/2018	Immune parameters to p67C antigen adjuvanted with ISA206VG correlate with protection against East Coast fever.
1/2018	Characterization of the Theileria parva sporozoite proteome.
4/2014	Use of "one-pot, mix-and-read" peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle.
10/2009	Adjuvant effect of bovine heat shock protein 70 on piroplasm surface protein, p33, of Theileria sergenti.
2/2006	Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes.
4/2005	Novel baculovirus-derived p67 subunit vaccines efficacious against East Coast fever in cattle.
3/2003	Immunity to East Coast fever in cattle induced by a polypeptide fragment of the major surface coat protein of Theileria parva sporozoites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vishvanath Nene Research Topics

Disease

9	Theileriasis 01/2022 - 03/2003
5	Infections 05/2018 - 04/2005
4	Malaria 12/2017 - 10/2002
1	Hepatitis B 01/2021
1	Malignant Catarrh 01/2019
1	Neoplasms (Cancer) 01/2019
1	Leukemia 01/2019
1	Parasitemia 01/2018
1	Vector Borne Diseases 12/2017
1	Body Weight (Weight, Body) 12/2017
1	Rift Valley Fever 02/2016
1	Cattle Diseases (Bovine Diseases) 04/2014
1	Protozoan Infections 02/2007
1	Persistent Infection 07/2005
1	Communicable Diseases (Infectious Diseases) 05/2003
1	Tick Infestations 06/2002

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 01/2022 - 06/2002
7	AntigensIBA 05/2018 - 02/2007
6	Proteins (Proteins, Gene)FDA Link 05/2018 - 06/2002
3	EpitopesIBA 01/2022 - 04/2014
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 03/2003
3	Subunit VaccinesIBA 02/2006 - 04/2005
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2016
2	AntibodiesIBA 05/2018 - 01/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	buparvaquoneIBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Thomsen-Friedenreich antibodiesIBA 01/2019
1	Neutralizing AntibodiesIBA 05/2018
1	Oxytetracycline (Terramycin)FDA Link 05/2018
1	InsecticidesIBA 12/2017
1	fipronilIBA 12/2017
1	BuffersIBA 12/2017
1	Adenovirus VaccinesIBA 02/2016
1	eprinomectinIBA 01/2016
1	Peptides (Polypeptides)IBA 03/2003
1	Amino Acids FDA Link 03/2003
1	Antimalarials (Antimalarial Agents)IBA 10/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2019
1	Insecticide-Treated Bednets 01/2016